Autor
Mostrando ítems 1-2 de 2
-
Identification of genetic variants associated with capecitabine-induced hand-foot syndrome through integration of patient and cell line genomic analyses.
Wheeler, Heather E; González-Neira, Anna; Pita, Guillermo; de la Torre Montero, Julio César; Alonso, Rosario; López-Fernández, Luis; Alba, Emilio; Martín, Miguel; Dolan, M Eileen (01/05/2014). -
Standard versus continuous administration of capecitabine in metastatic breast cancer (GEICAM/2009-05): a randomized, noninferiority phase II trial with a pharmacogenetic analysis
Martín, Miguel; Martínez, Noelia; Ramos, Manuel; Calvo, Lourdes; Lluch, Ana; Zamora, Pilar; Muñoz, Montserrat; Carrasco, Eva; Caballero, Rosalía; García-Saénz, Jose Angel; Guerra, Eva; Caronia, Daniela; Casado, Antonio; Ruiz-Borrego, Manuel; Hernando, Blanca; Chacón, Jose Ignacio; de la Torre Montero, Julio César; Jimeno, Maria Angeles; Heras, Lucía; Alonso, Rosario (19/01/2015).